Who is sponsoring NCT05171595?

NCT05171595 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05171595?

Interventions in NCT05171595: Lifetouch single-lead ECG monitoring, high-sensitive TnT measurements.

What condition does NCT05171595 study?

NCT05171595 studies Myocardial Injury.

Is NCT05171595 still recruiting?

NCT05171595 is currently completed. Last updated 12 January 2022.

Last reviewed 2022-01-12 · How we verify

NCT05171595

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real Time ST-segment Deviation Detection in High-risk Patients Detected by Wireless Single-lead ECG

Completed Last updated 12 January 2022

What this trial tests

trial testing Lifetouch single-lead ECG monitoring in Myocardial Injury in 698 participants. Completed in 9 June 2020.

Timeline

20 February 2018

Primary endpoint
9 June 2020

9 June 2020

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Status	Completed
Study type	OBSERVATIONAL
Enrollment	698
Start date	20 February 2018
Primary completion	9 June 2020
Estimated completion	9 June 2020
Sites	1 location across Denmark

Drugs / interventions tested

Lifetouch single-lead ECG monitoring
high-sensitive TnT measurements

Conditions studied

Myocardial Injury — all drugs for Myocardial Injury →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Myocardial Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study primarily aims to describe the frequency of significant ST-deviations, defined as ECG-ST-deviations \<-0.255 or \>0.245 mV for a minimum duration of 30 minutes as measured by a single-lead ECG in patients admitted with AECOPD or following major abdominal surgery. Secondarily we will describe the frequency of ST-deviations \<-0.255 or \>0.245 mV for a minimum duration of 1, 10 and 20 minutes, respectively, as well as for patients with ST-deviations \<-0.1 or \>0.1 mV for a minimum duration of 1, 10, 20 and 30 minutes, respectively. Lastly, we will investigate the association between ST-deviations and subsequent myocardial injury while adjusting for known risk factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myocardial Injury

Currently open trials in the same condition.

NCT06982404 — ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biop · recruiting
NCT06279000 — Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery · Phase 3 · recruiting
NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
NCT06705023 — Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an · Phase 2 · recruiting
NCT06296212 — Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial In · Phase 3 · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05171595 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 12 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05171595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing